Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs35880645 | chr16:1768326 | C/T | 1.76E-11 | 174 | 25.67 | 18.2 | 4.52 | KM Plot |
PCPG | rs35885576 | chr2:242566706 | T/C | 1.07E-10 | 172 | 25.67 | 21.9 | 10.3 | KM Plot |
PCPG | rs35895310 | chr8:121390722 | G/C | 5.09E-6 | 176 | 26.88 | 25 | 19.87 | KM Plot |
PCPG | rs35897291 | chr14:74415032 | T/C | 4.36E-6 | 173 | 25.08 | 30.33 | 10.43 | KM Plot |
PCPG | rs35899271 | chr14:74457121 | A/G | 3.51E-6 | 177 | 25.17 | 30.93 | 10.3 | KM Plot |
PCPG | rs35900502 | chr15:43373929 | T/C | 2.31E-14 | 177 | 25.87 | 24.53 | 3.17 | KM Plot |
PCPG | rs35918470 | chr16:89949564 | C/CA | 0.000161 | 174 | 25.77 | 23.37 | 36.37 | KM Plot |
PCPG | rs35931400 | chr14:74627684 | C/G | 1.98E-5 | 177 | 25.4 | 26.92 | 10.43 | KM Plot |
PCPG | rs35953500 | chr1:40497708 | C/T | 6.93E-5 | 175 | 24.85 | 24.88 | 36.73 | KM Plot |
PCPG | rs35957552 | chr2:242555316 | G/A | 4.04E-5 | 178 | 25.87 | 26.47 | 20.2 | KM Plot |
PCPG | rs35969769 | chr16:1694922 | C/CA | 5.46E-5 | 176 | 25.08 | 28.45 | 19.83 | KM Plot |
PCPG | rs35981772 | chr1:40519082 | C/T | 0.000336 | 174 | 25.2 | 27.27 | 25.17 | KM Plot |
PCPG | rs35981926 | chr16:71500755 | A/T | 1.11E-16 | 172 | 24.52 | 29.57 | 3.17 | KM Plot |
PCPG | rs35988159 | chr16:1764887 | A/G | 6.54E-5 | 174 | 25.6 | 15.85 | 17.77 | KM Plot |
PCPG | rs35988237 | chr5:179478528 | C/T | 0.000238 | 176 | 24.17 | 29.95 | 14.83 | KM Plot |